Question
Biological E vaccine has received DGCI approval to conduct phase 2/3 trials on children. What is the name of its COVID vaccine candidate?
Answer: Option B
Was this answer helpful ?
Hyderabad-based Biological E Limited got approval from the Drug Controller General of India (DCGI) to conduct Phase 2 & 3 clinical trials for its COVID-19 vaccine Corbevax on children aged between 5 and 18 years of age with certain conditions.
Was this answer helpful ?
Submit Solution